Red flag symptoms that necessitate same-day medical contact include: Blood in stools (visible red blood or black, tarry stools) Severe abdominal pain that is persistent, severe, or radiating to the back (which may indicate pancreatitis, a rare but serious side effect) Signs of dehydration : decreased urination, dark urine, dizziness upon standing, extreme thirst, or confusion Fever above 100.4F (38C) accompanying diarrhea Pain in the upper right abdomen , possibly with fever or yellowing of skin/eyes (signs of gallbladder disease, which can occur with GLP-1 medications) Inability to keep down fluids due to concurrent vomiting If you experience severe vomiting or diarrhea leading to dehydration, you may need to temporarily pause your medication until speaking with your healthcare provider, as severe dehydration can lead to acute kidney injury
In addition, while the homogenous nature of the prescribed dietary intake deficit, physical activity goal and counseling frequency provided consistency, it may not fully reflect the need for approaches tailored to the health profiles of individuals or to different populations in clinical practice
Itching and skin irritation affect some people using semaglutide for weight loss, though dermatological side effects are not among the most commonly reported adverse events in clinical trials
And when adjustments arent enough, your provider can fine-tune your plan rather than leaving you to tough it out
Tirzepatide is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus (as Mounjaro) and, more recently, for chronic weight management in adults with obesity or overweight with weight-related comorbidities (as Zepbound)
Some of those events required hospitalization
